In vivo effects of APP are not exacerbated by BACE2 co-overexpression: Behavioural characterization of a double transgenic mouse model

Amino Acids

Volumn 39, Issue 5, 2010, Pages 1571-1580

  Azkona, Garikoitz ^a,b,c   Levannon, Ditsa ^d   Groner, Yoram ^d   Dierssen, Mara ^a,b  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Alzheimer disease; APP; BACE2; Chromosome 21; Down syndrome

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 2;

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENOTYPE; IN VIVO STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

MUS; MUS MUSCULUS;

EID: 78449295431     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-010-0662-8     Document Type: Article

References (33)

1. F Acquati M Accarino C Nucci P Fumagalli L Jovine S Ottolenghi R Taramelli 2000 The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region FEBS Lett 468 59 64 1:CAS:528:DC%2BD3cXhtFamtLs%3D 10.1016/S0014-5793(00)01192-3 10683441
2. X Altafaj M Dierssen C Baamonde E Marti J Visa J Guimera M Oset J Gonzalez J Florez C Fillat X Estivill 2001 Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome Hum Mol Genet 10 1915 1923 1:CAS:528:DC%2BD3MXntlSgsb0%3D 10.1093/hmg/10.18.1915 11555628
3. G Arqué V Fotaki D Fernández M Martínez de Lagrán ML Arbonés M Dierssen 2008 Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for Dyrk1A PLoS ONE 3 e2575 10.1371/journal.pone.0002575 18648535
4. G Arqué M Martínez de Lagrán ML Arbonés M Dierssen 2009 Age-associated motor and visuo-spatial learning phenotype in Dyrk1A heterozygous mutant mice Neurobiol Dis 36 312 319 10.1016/j.nbd.2009.07. 027 19660545
5. G Azkona A Amador-Arjona C Obradors-Tarrago E Varea G Arque R Pinacho C Fillat S de la Luna X Estivill M Dierssen 2010 Characterization of a mouse model overexpressing beta-site APP-cleaving enzyme 2 reveals a new role for BACE2 Genes Brain Behav 9 2 160 172 1:CAS:528:DC%2BC3cXks1SmsL8%3D 10.1111/j.1601-183X.2009.00538.x 19840121
6. G Basi N Frigon R Barbour T Doan G Gordon L McConlogue S Sinha M Zeller 2003 Antagonistic effects of beta-site amyloid precursor protein-cleaving enzymes 1 and 2 on beta-amyloid peptide production in cells J Biol Chem 278 31512 31520 1:CAS:528:DC%2BD3sXmsVOntr8%3D 10.1074/jbc.M300169200 12801932
7. J Busciglio A Pelsman C Wong G Pigino M Yuan H Mori BA Yankner 2002 Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome Neuron 33 677 688 1:CAS:528:DC%2BD38XitF2nsLc%3D 10.1016/S0896-6273(02)00604-9 11879646
8. MS Cheon M Fountoulakis M Dierssen JC Ferreres G Lubec 2001 Expression profiles of proteins in fetal brain with Down syndrome J Neural Transm 61 311 319
9. MS Cheon M Dierssen SH Kim G Lubec 2008 Protein expression of BACE1, BACE2 and APP in Down syndrome brains Amino Acids 35 339 343 1:CAS:528:DC%2BD1cXpvVKgtrY%3D 10.1007/s00726-007-0618-9 18163181
10. ME Coussons-Read LS Crnic 1996 Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field Behav Genet 26 7 13 1:STN:280:DyaK2s%2FgsFChug%3D%3D 10.1007/BF02361154 8852727
11. M Dierssen F Màrmol NM Vivas V Clos A Badia 1992 Posttrain administration of 9-amino-1,2,3,4-tetrahydroacridine enhances passive avoidance retention and decreases β-adrenoceptor linked cyclic AMP formation in middle-aged rats Brain Res 586 117 120 1:CAS:528:DyaK38XlsVegt7o%3D 10.1016/0006-8993(92)91379-S 1380875
12. M Dierssen V Fotaki M Martinez de Lagran M Gratacos M Arbones C Fillat X Estivill 2002 Neurobehavioral development of two mouse lines commonly used in transgenic studies Pharmacol Biochem Behav 73 19 25 1:CAS:528: DC%2BD38XksFKksL0%3D 10.1016/S0091-3057(02)00792-X 12076721
13. RM Escorihuela A Fernández-Teruel IF Vallina C Baamonde M Dierssen A Tobeña J Flórez 1995 A behavioral assessment of Ts65Dn mice: a putative Down syndrome model Neurosci Lett 199 143 146 1:CAS:528: DyaK2MXptVems7s%3D 10.1016/0304-3940(95)12052-6 8584244
14. RM Escorihuela C Martínez-Cué IF Vallina C Baamonde M Dierssen A Tobeña J Flórez A Fernández-Teruel 1998 Impaired short- and long-term memory in Ts65Dn mice Neurosci Lett 247 171 174 1:CAS:528:DyaK1cXis1yju7s%3D 10.1016/S0304-3940(98)00317-6 9655620
15. M Farzan CE Schnitzler N Vasilieva D Leung H Choe 2000 BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein Proc Natl Acad Sci USA 97 9712 9717 1:CAS:528:DC%2BD3cXmtVentL8%3D 10.1073/pnas.160115697 10931940
16. I Ferrer M Barrachina B Puig M Martínez de Lagrán E Martí T Gómez-Isla J Avila M Dierssen 2005 Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, dementia with Lewy bodies, Pick disease and related transgenic models Neurobiol Dis 20 392 400 1:CAS:528:DC%2BD2MXhtFCjs7bN 10.1016/j.nbd.2005.03.020 16242644
17. C Harris-Cerruti A Kamsler B Kaplan B Lamb M Segal Y Groner 2004 Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein Eur J Neurosci 19 1174 1190 10.1111/j.1460-9568.2004.03188.x 15016076 (correction)
18. DM Holtzman D Santucci J Kilbridge J Chua-Couzens DJ Fontana SE Daniels RM Johnson K Chen Y Sun E Carlson E Alleva CJ Epstein WC Mobley 1996 Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome Proc Natl Acad Sci USA 93 13333 13338 1:CAS:528: DyaK28XmvFSnsLw%3D 10.1073/pnas.93.23.13333 8917591
19. I Hussain D Powell DR Howlett DG Tew TD Meek C Chapman IS Gloger KE Murphy CD Southan DM Ryan TS Smith DL Simmons FS Walsh C Dingwall G Christie 1999 Identification of a novel aspartic protease (Asp 2) as beta-secretase Mol Cell Neurosci 14 419 427 1:CAS:528:DyaK1MXnt1Chsrs%3D 10.1006/mcne.1999.0811 10656250
20. I Hussain DJ Powell DR Howlett GA Chapman L Gilmour PR Murdock DG Tew TD Meek C Chapman K Schneider SJ Ratcliffe D Tattersall TT Testa C Southan DM Ryan DL Simmons FS Walsh C Dingwall G Christie 2000 ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site Mol Cell Neurosci 16 609 619 1:CAS:528:DC%2BD3cXotFWgsLo%3D 10.1006/mcne.2000.0884 11083922
21. BT Lamb SS Sisodia AM Lawler HH Slunt CA Kitt WG Kearns PL Pearson DL Price JD Gearhart 1993 Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice Nat Genet 5 22 30 1:CAS:528: DyaK3sXmt1egsbo%3D 10.1038/ng0993-22 8220418 (corrected)
22. Lott IT, Dierssen M (2010) Down syndrome: neurological complications and cognition. Lancet Neurol (in press)
23. M Martínez de Lagrán X Altafaj X Gallego E Martí X Estivill C Fillat M Dierssen 2004 Motor phenotypic alterations in TgDyrk1A transgenic mice implicate DYRK1A in Down syndrome motor dysfunction Neurobiol Dis 15 32 142 10.1016/j.nbd.2003.10.002
24. MP Mattson 2004 Pathways towards and away from Alzheimer's disease Nature 430 631 639 1:CAS:528:DC%2BD2cXmt1Gis7o%3D 10.1038/nature02621 15295589
25. GM Murphy Jr LF Eng WG Ellis G Perry LC Meissner JR Tinklenberg 1990 Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease Brain Res 537 102 108 1:CAS:528:DyaK3MXnvFKjtQ%3D%3D 10.1016/0006-8993(90)90345-C 1707726
26. DC Rogers EM Fisher SD Brown J Peters AJ Hunter JE Martin 1997 Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment Mamm Genome 8 711 713 1:STN:280: DyaK2svmvValtw%3D%3D 10.1007/s003359900551 9321461
27. H Sago EJ Carlson DJ Smith J Kilbridge EM Rubin WC Mobley CJ Epstein TT Huang 1998 Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities Proc Natl Acad Sci USA 95 6256 6261 1:CAS:528:DyaK1cXjtlKns7g%3D 10.1073/pnas.95.11.6256 9600952
28. K Sambamurti R Kinsey B Maloney YW Ge DK Lahiri 2004 Gene structure and organization of the human beta-secretase (BACE) promoter FASEB J 18 1034 1036 1:CAS:528:DC%2BD2cXkslWiur0%3D 15059975
29. A Solans X Estivill S de La Luna 2000 A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein beta-secretase Cytogenet Cell Genet 89 177 184 1:CAS:528:DC%2BD3cXms1Slt7s%3D 10.1159/000015608 10965118
30. X Sun G He W Song 2006 BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome FASEB J 20 1369 1376 1:CAS:528:DC%2BD28Xmslegsrw%3D 10.1096/fj.05-5632com 16816112
31. R Vassar BD Bennett S Babu-Khan S Kahn EA Mendiaz P Denis DB Teplow S Ross P Amarante R Loeloff Y Luo S Fisher J Fuller S Edenson J Lile MA Jarosinski AL Biere E Curran T Burgess JC Louis F Collins J Treanor G Rogers M Citron 1999 Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 735 741 1:CAS:528: DyaK1MXntFWit74%3D 10.1126/science.286.5440.735 10531052
32. KE Wisniewski AJ Dalton C McLachlan GY Wen HM Wisniewski 1985 Alzheimer's disease in Down's syndrome: clinicopathologic studies Neurology 35 957 961 1:STN:280:DyaL2M3ktV2msg%3D%3D 3159974
33. R Yan JB Munzner ME Shuck MJ Bienkowski 2001 BACE2 functions as an alternative alpha-secretase in cells J Biol Chem 276 34019 34027 1:CAS:528:DC%2BD3MXmslyltbg%3D 10.1074/jbc.M105583200 11423558